References
1.- Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. New Engl J Med 2014; 371: 1039-1049
2.- Garcea G, Neal CP, Pattender CJ, Steward WP, Berry DP. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005; 41: 2213-2236
3.- Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oresic K, Turk V. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002; 383: 1035-1044
4.- Gocheva V, Wang HW, gadea BB, Shree T Hunter KE, Garfall AL, Berman T, Joyce JA. Il-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 2010; 24: 241-255
5.- Nomura T, Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1-9
6.- Vasiljeva O, Papazoglou A, Kruger A, Brodoefel H, Korovin M, Deussing J, Augustin N, Nielsen BS, Almholt K, Bogyo M, Peters C, Reinheckel T. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 2006; 66: 5242-5250
7.- Aggarwal N, Sloane BF. Cathepsin B: multiple roles in cancer. Proteomics Clin Appl 2014; 8: 427-437
8.- Joyce JA, Hanahan D. Multiple roles for cysteine cathepsins in cancer. Cell Cycle 2004; 3: 1516-1519
9.- Reinheckel T, Peters C, Krüger A, Turk B, Vasiljeva O. Differential impact of cysteine cathepsins on genetic mouse models of the novo carcinogenesis: cathepsin B as emerging therapeutic target. Front Pharmacol 2012; 3: 133
10.- Sulpizio S, Franceschini N, Piatelli A, Di Sebastiano P, Innocenti P, Selvaggi F. Cathepsins and pancreatic cancer: the 2012 update. Pancreatology 2012; 12: 395-401
11.- Hwang JH; Lee SH, Lee KH, Kim H, Ryu JK, Yoon YB, Kim YT. Cathepsin B is a target of hedgehog signaling in pancreatic cancer. Cancer Lett 2009; 273: 266-272
12.- Zhang C, Sun J, Liu D, Cui Y, Liu S, Sun H. Preliminary research on yhe pathological role of cathepsin-B in subcutaneous heteroplastic pancreatic carcinoma in nude mice. Chin Med J 2009; 122: 2489-2496
13.- Gopinathan A, de Nicola G, Frese K, Cook N, Karreth FA, Mayerle J, Lerch MM, Reincheckel T, Tuveson DA. Cathepsin B promotes the progression of pancreatic ductal carcinoma in mice. Gut 2012;61:877-884
14,- Von Burstin J, Eser S, Seidler B, Meining A, Bajbouj M, Mages J, Lang R, Kind A, Schnieke A, Schmid R, Schneider G, Saur D. Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice. Int J Cancer 2008; 123: 2138-2147
15.- Leto G, Tumminello FM, Pizzolanti G, Montalvo G, Zorreéis M, Carroccio A, Hipólito S, Gebbia N. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 1997; 14: 22-27
16.- Azuma T, Hirai M, Ito S, Yamamoto K, Taggart RT, Matsuba T, Yasukawa K, Uno K, Hayakumo T, Nakajima M. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report. Int J Cancer 1996; 67: 492-497
17.- Cruz-Monserrate Z, Abd-Elgaliel W, Grote T, Deng D, Ji B, Arumugam T, Wang H, Tung C, Logsdon C. Detection of pancreatic tumours and precursor lesions by cathepsin E activity in mouse models. Gut 2012; 61; 1315-1322
18. - Eser S, Messer M, Eser P, von Werder A, Seidler B, Bajbouj M, Vogelman R, Meining A, von Brurstin, Algül, Pagel P, Schinieke AE, Esposito I, Schmid RM, Schneider G, Saur D. in vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. PNAS 2011; 108: 9945-9950
19.- UICC TNM Classification Edition 7 published 2009 and went into effect 2010
20.- Niedergethmann M, Wostbrock B, Sturm JW, Willeke F, Post S, Hildenbrand R. Pancreatic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma. Pancreas 2004; 29: 204-211
21.- Niedergethmann M; Hildenbrand R, Wolf G, Verbeke CS, Richter A, Post S. Angiogenesis and cathepsin exxpression are prognostic factors in pancreatic adenocarcinoma after curative resection. Int J Pancreatol 2000; 28: 31-39
22.- Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, Fonseca L, Miyazaki I. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastasic lesions. Br J Cancer 1994; 69: 152-156
23.- Gocheva V, Wang HW, Gadea BB, Shree T Hunter KE, Garfall AL, Berman T, Joyce JA. Il-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 2010; 24: 241-255
24.- Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Fong-Ying Tsai, Greenbaum DC, Hager JH, Bogyo M, Hanahan D. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004; 5: 443-453
25.- Gocheva V, Chen X, Peters C, Reinheckel T. Joyce J. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 2010; 391: 937-945